Earnings call transcript: Amara Raja posts Q2 2026 EPS beat, revenue miss

Amara Raja reported EPS of $11.90 versus a $11.63 forecast, but revenue of $38.96 billion missed the $40.19 billion estimate; the stock was down 1.47% at $698. Consolidated revenue was INR 4,108 crore, while standalone EBITDA margin fell to 10.1% and consolidated margin declined 1.3 percentage points year over year to 8.8%, amid raw-material inflation and investment spending. Management expects medium-term lead-acid growth of 8%–10% and plans INR 2,320 crore of investment in a 5-gigawatt LFP cell gigafactory and pack capacity, with completion expected within 30 months.

Analysis

The central risk is not the modest forecast miss; it is whether lead-acid pricing can catch up with input inflation without sacrificing volume or OEM relationships. Price increases lagged further cost rises, while OEM mix is dilutive, so reported volume growth may not translate into near-term earnings growth. A better quarter-on-quarter margin is not yet evidence of a durable recovery. Verify the next two quarters’ gross-margin bridge, price realization versus lead and acid costs, and aftermarket share before underwriting management’s recovery case.

The transition is also less de-risked than the capacity announcements imply. New-energy returns depend on ramp-up, but management says roughly 70% of BESS cells are imported and local systems carry a 10–15% cost disadvantage to Chinese imports. That leaves exposure to import pricing, currency and policy support; additional capacity could compound low returns if utilization or pricing disappoints. Meanwhile, lead-acid lines are not fungible with lithium production, limiting the value of legacy assets if substitution accelerates over the longer term. Exide Industries is a relevant peer to monitor for relative pricing and market-share signals, not an automatic hedge without comparative valuation and earnings data.

Near term, margin and cash-conversion evidence matter more than the small EPS beat. Over 1–3 months, input-cost trends and pricing actions are the key catalysts; over 6–18 months, BESS utilization, cell qualification and capex discipline determine whether the transition earns its cost of capital. The contrarian risk to an outright short is that easing inputs and price realization could restore lead-acid margins before lithium investment contributes. The article’s valuation claim is not independently supported here, and its financial figures mix scopes/currencies; validate against filings before acting.

Key Decisions for Investors

• Avoid chasing the EPS beat; keep exposure neutral-to-underweight until reported margins show recovery alongside evidence that price realization is keeping pace with raw-material costs.
• Treat a long in Amara Raja Energy & Mobility as a conditional 1–3 month setup, not a dip-buy: reconsider only after sequential margin improvement and confirmation of BESS commercial ramp-up; invalidate the thesis if margins weaken again or utilization guidance slips.
• Track Exide Industries as a relative-performance comparator, but do not initiate a pair trade without verified peer valuation, margin and market-share data.
• Monitor cell-import costs, currency and any policy changes affecting domestic BESS economics; these could either narrow the cost gap or undermine the planned utilization and return assumptions.